Biosound Esaote of Indianapolis last month introduced two cardiovascular color flow ultrasound systems. The two new systems, Caris and Megas, were cleared by the Food and Drug Administration last year.Caris, first introduced at the American College of
Biosound Esaote of Indianapolis last month introduced two cardiovascular color flow ultrasound systems. The two new systems, Caris and Megas, were cleared by the Food and Drug Administration last year.
Caris, first introduced at the American College of Cardiology meeting in New Orleans in March, was designed for the mobile market or hospitals that require a second, portable, cardiovascular ultrasound system. Highly portable, Caris is 9 inches high and weighs 35 pounds.
Megas was introduced at this years meeting of the American Society of Echocardiology in Washington, DC, and is aimed at a market segment new to Biosound: the large group, hospital, or clinic that requires a small, low-cost system with phased array cardiovascular technology. According to Biosound, Megas is the only portable phased array cardiovascular ultrasound system in the world. It boasts ASIC and FPGA microcircuitry and uses a 48-pound mainframe. Megas has both conventional and color Doppler, and can be used with a variety of probes, including linear array and convex array technologies.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.